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Abstract
Background: As an epigenetic regulator, the transcriptional intermediary factor 1β (TIF1β)/
KAP1/TRIM28) has been linked to gene expression and chromatin remodeling at specific loci by
association with members of the heterochromatin protein 1 (HP1) family and various other
chromatin factors. The interaction between TIF1β and HP1 is crucial for heterochromatin
formation and maintenance. The HP1-box, PXVXL, of TIF1β is responsible for its interaction with
HP1. However, the underlying mechanism of how the interaction is regulated remains poorly
understood.
Results: This work demonstrates that TIF1β is phosphorylated on Ser473, the alteration of which
is dynamically associated with cell cycle progression and functionally linked to transcriptional
regulation. Phosphorylation of TIF1β/Ser473 coincides with the induction of cell cycle gene cyclin
A2 at the S-phase. Interestingly, chromatin immunoprecipitation demonstrated that the promoter
of cyclin A2 gene is occupied by TIF1β and that such occupancy is inversely correlated with Ser473
phosphorylation. Additionally, when HP1β was co-expressed with TIF1β/S473A, but not TIF1β/
S473E, the colocalization of TIF1β/S473A and HP1β to the promoters of Cdc2 and Cdc25A was
enhanced. Non-phosphorylated TIF1β/Ser473 allowed greater TIF1β association with the
regulatory regions and the consequent repression of these genes. Consistent with possible
inhibition of TIF1β's corepressor function, the phosphorylation of the Ser473 residue, which is
located near the HP1-interacting PXVXL motif, compromised the formation of TIF1β-HP1
complex. Finally, we found that the phosphorylation of TIF1β/Ser473 is mediated by the PKCδ
pathway and is closely linked to cell proliferation.
Conclusion: The modulation of HP1β-TIF1β interaction through the phosphorylation/de-
phosphorylation of TIF1β/Ser473 may constitute a molecular switch that regulates the expression
of particular genes. Higher levels of phosphorylated TIF1β/Ser473 may be associated with the
expression of key regulatory genes for cell cycle progression and the proliferation of cells.
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Transcriptional intermediary factor TIF1β and heterochro-
matin protein 1 profoundly impact the regulation of the
structure and function of chromatin [1]. The heterochro-
matin protein 1 (HP1) family of proteins (HP1α, HP1β,
and HP1γ) participates in gene silencing by forming hete-
rochromatic structures [2,3]. HP1 exhibits distinct nuclear
localization patterns: HP1α nassociates with centromeres
while HP1β and HP1γ are largely localized in distinct
nuclear regions. The nuclear arrangement of HP1 proteins
and TIF1β is differentiation pathway-specific, and appears
to be more important than changes in the levels of these
proteins, which are relatively stable during all of the
induced differentiation processes [4,5].
HP1 proteins comprise an N-terminal chromodomain, a
C-terminal chromoshadow domain and a hinge domain
[3,6,7]. The chromodomain functions as a protein inter-
action domain, bringing together different proteins in
multi-protein complexes and recruiting them to hetero-
chromatin. This domain binds to particular proteins
which contain an HP1 box (PXVXL) and function at the
transcriptional level [2,8-10]. The chromoshadow
domain mediates the formation of homodimer. TIF1β
interacts with the chromodomain of dimeric HP1β via the
HP1 box of TIF1β in the HP1-interaction domain [6]. The
TIF1β ntranscriptional repression activity depends on the
interaction between TIF1β and HP1 [11]. This interaction
is essential in the relocation of TIF1β from euchromatin to
heterochromatin that accompanies the differentiation of
primitive endoderm-like cells [12]. TIF1β is proposed to
function as a universal co-repressor protein for the KRAB
zinc finger protein (KRAB-zfp) superfamily of transcrip-
tional repressors. The recruitment of HP1 proteins by the
KRAB-TIF1β complex to specific loci within the genome
via the formation of heterochromatin-like complexes may
thus silence gene activity. Gene-specific repression may be
a consequence of the formation of such complexes [13].
It has been reported that TIF1β directly interacts with the
histone methyltransferase SETDB1, which methylates spe-
cifically histone H3/Lys9 within euchromatin [14]. Deple-
tion of endogenous levels of TIF1β by siRNA significantly
inhibited the KRAB-mediated transcriptional repression
of a chromatin template and inhibited cell cycle progres-
sion. Cell death may occur if TIF1β is severely depleted by
siRNA knockdown [unpublished observations, [15-17]].
Similarly, the knock-down of cellular levels of HP1 pro-
teins and SETDB1 by siRNA attenuated KRAB-TIF1β
repression. The physiological targets and functions of
TIF1β remain unclear. Its interactions with chromatin
modification factors such as HDAC1, SETDB1 and HP1
correlate with its activities in regulating the chromatin
structure and heterochromatin formation, resulting in
epigenetic silencing of reporter genes [18]. A TIF1β-con-
taining multiprotein complex regulates various protein
activities or genes [19]. The activity of TIF1β may be regu-
lated by posttranslational modifications. For example,
TIF1β is rapidly phosphorylated by members of the phos-
phatidylinositol-3 kinase-like family of kinases following
DNA damage. Phosphorylated TIF1β colocalizes with
numerous damage response factors at DNA lesions [20].
Recent genetic and proteomic studies in mice have shown
that TIF1β is a developmental regulatory protein perform-
ing cellular function(s) that are critical to early embryonic
development, and is a component of the interactive pro-
tein network for the pluripotency of embryonic stem cells
[21,22]. The binding of the TIF1β corepressor to the retro-
virus primer binding site is responsible for the epigenetic
silencing of retrovirus transcription [17]. Therefore, the
interaction between TIF1β and HP1 or other transcription
factors may account for the regulation of gene expression.
Phosphorylation of both human and mouse TIF1β/
Ser473 has been identified by nuclear phosphoprotein
analysis of HeLa and WEHI-231 cells [23,24]. Ser473 is
located in the HP1-interacting domain of TIF1β – close to
the HP1 box (amino acids 486–490, PXVXL). The conser-
vation of TIF1β/Ser473 phosphorylation in various cell
lines from different species motivated this investigation of
the functional significance of this modification.
The coil-coiled domain of TIF1β binds to E2F1 and inhib-
its its activity [16]. The induction of cyclin A, Cdc2 and
Cdc25A genes depends on E2F [25,26]. Cyclin A is a cell
cycle-regulating protein that participates in S-phase con-
trol and mitosis in mammalian somatic cells. The pro-
moter of cyclin A is repressed during the G1 phase of the
cell cycle and is activated at S-phase entry [27]. Cdc2 per-
mits the transition from G1 through S in conjunction with
cyclin E [28]. These E2F downstream genes are important
to normal cell cycle progression [29].
This report shows that TIF1β participates in the regulation
of cyclin A2, Cdc2 and Cdc25A gene expression. This regu-
lation depends on the interaction between TIF1β and
HP1β, which is itself regulated by the phosphorylation
state of TIF1β/Ser473. The experimental results suggest
that the TIF1β/Ser473-unphosphorylated form binds
more strongly than the phosphorylated form to the pro-
moters of Cyclin A2, Cdc2, and Cdc25A genes. The phos-
phorylation/de-phosphorylation of TIF1β/Ser473 may
serve as a molecular switch regulating its interaction with
HP1β and gene expression.
Results
Characterization of TIF1β and phosphorylated TIF1β/
Ser473 antibodies
Western blotting of interphase HeLa cell extract was per-
formed to characterize the specificity of monoclonal anti-Page 2 of 16
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was detected (Figure 1A). 293T cell-expressed FLAG-TIF1β
was recognized either by 20A1 or monoclonal anti-FLAG
antibody, M2 (Figure 1A), demonstrating that mono-
clonal antibody 20A1 is specific to TIF1β.
The specificity of rabbit anti-phospho-Ser473 antibody
was characterized by Western blotting of interphase 293T
cell extract with rabbit anti-TIF1β/phospho-Ser473 anti-
body (S473) or 20A1 monoclonal antibody. The phos-
phorylated TIF1β/Ser473 signal was diminished after calf
intestine alkaline phosphatase (CIP) treatment (Figure
1B). Ectopically-expressed FLAG-TIF1β was immunopre-
cipitated from 293T cells with M2 beads and treated with
CIP to examine whether the signal was due to the phos-
phorylation of TIF1β/S473. 20A1 and S473 antibodies
both recognized FLAG-TIF1β, but the signal recognized by
the S473 antibody disappeared upon CIP treatment (Fig-
ure 1C). Unlike the FLAG-TIF1β, mutants FLAG-TIF1β/
S473A and FLAG-TIF1β/S473E were not detected by S473
antibody (Figure 1C). These data demonstrate that while
20A1 or S473 antibodies recognize the same protein,
TIF1β, the S473 antibody specifically recognizes phos-
phorylated TIF1β/S473.
Phosphorylation of TIF1β/Ser473 is dynamically regulated 
during cell cycle progression
Although TIF1β is known to be a general corepressor pro-
tein, few studies have suggested that TIF1β has a critical
function in cell cycle progression. The phosphorylation of
TIF1β/Ser473 was identified in HeLa and WEHI cells at
interphase [23,24]. Since Ser473 is located near the HP1-
binding motif, an intriguing question arises: what is the
functional consequence, if any, of the phosphorylation of
TIF1β/Ser473? To elucidate the phosphorylation state of
TIF1β/Ser473 during cell cycle progression, Western blot-
ting was performed with lysates from synchronized HeLa
cells. Cells were synchronized to G1/S transition using
double thymidine block. Phosphorylated TIF1β/Ser473
was almost undetectable at the G1/S boundary under the
thymidine block (Figure 2A, 0 hr, S473) but the phospho-
rylation of TIF1β/Ser473 was maximal 1 hour post-release
from the thymidine block, during early S phase (Figure
2A, 1 hr, S473). The level of phosphorylated TIF1β/Ser473
decreased thereafter for 2 hours during the mid to late S-
phase cell cycle progression. The level of total TIF1β
remained relatively constant (Figure 2A, 20A1). The ele-
vated cyclin A and decreased cyclin B evidenced the G1/S
to S cell cycle progression of thymidine release (Figure
2A).
HeLa cells were synchronized to prometaphase by noco-
dazole treatment. The level of phosphorylated TIF1β/
Ser473 was determined from HeLa extracts collected from
0 to 8 hours after nocodazole were removed. The phos-
Characterization of monoclonal anti-TIF1β (20A1) and rabbit anti-phosphorylated TIF1β/Ser473 (S473) antibodiesFigure 1
Characterization of monoclonal anti-TIF1β (20A1) and rabbit 
anti-phosphorylated TIF1β/Ser473 (S473) antibodies. (A) HeLa cell 
lysate were probed with anti-TIF1β monoclonal antibody, 20A1 (lane 1). 
Lysate from 293T cells transfected with FLAG-TIF1β were probed with 
20A1 antibody (lane 2) or anti-Flag monoclonal antibody, M2 (lane 3). (B) 
Whole cell extracts were prepared from 293T cells and incubated in the 
absence (lanes 1 and 3) or presence (lanes 2 and 4) of CIP (30 U) for 30 
min at 37°C. Western blotting was performed with antibodies indicated. 
(C) M2-beads purified FLAG-TIF1β from 293T cells were treated without 
(lane 1) or with (lane 2) CIP (30U) for 30 min. Western blot was probed 
with rabbit anti-TIF1β/Ser473 antibody (S473), anti-Flag antibody (M2), 
and anti-TIF1β antibody (20A1). Wild-type FLAG-TIF1β (lane 3), FLAG-
TIF1β/S473A (lane 4) or FLAG-TIF1β/S473E (lane 5), were immunoprecip-
itated by M2-beads, resolved in SDS-PAGE, transferred onto membrane 
and probed with antibodies as indicated.Page 3 of 16
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Phosphorylation of TIF1β/Ser473 is dynamically regulated during cell cycle progressionFigure 2
Phosphorylation of TIF1β/Ser473 is dynamically regulated during cell cycle progression. (A) HeLa cells were arrested at G1/S boundary by 
double thymidine block and released into S phase for three hours. The levels of TIF1β and phosphorylated TIF1β/Ser473 were probed with 20A1 and S473 
antibodies. The protein levels of cyclin A, cyclin B1, or α-tubulin were also shown. (B) HeLa cells were synchronized by nocodazole (1 μM) treatment for 
16 hours. Mitotic shake off cells were collected and released for 8 hours. The levels of TIF1β and phosphorylated TIF1β/Ser473 were probed with 20A1 
and S473 antibodies. The protein levels of cyclin B1, phosphorylated Histone H3 S10 (H3S10), or α-tubulin were also probed as indicated. The relative 
phosphorylation level of TIF1β/Ser473 was compared by quantitative determination of the images from Western blots (by ImageGauge software, normal-
ized to individual TIF1β level) at each time point (shown in the lower panel). (C) HeLa cells were arrested at G1 phase by serum starvation for three days 
and released to S phase by serum addition. The levels of TIF1β and phosphorylated TIF1β/Ser473 were probed with 20A1 and S473 antibodies. The pro-
tein levels of cyclin A, cyclin B1, and α-tubulin were also probed as indicated. HeLa cells at 0 hr (G1) or 2 hours after serum addition (early-S) were immu-
nostained with 20A1 (red) and S473 (green) antibodies, DNA was counter stained with DAPI (blue). (D) Immunostaining of ectopically expressed FLAG-
TIF1βs. FLAG-TIF1β/S473A (column 1) or FLAG-TIF1β/S473E (column 2) and wild-type FLAG-TIF1β (column 3) were transiently transfected into HeLa 
cells. Cells were fixed at 36 hours after transfection and co-stained with M2 (red) and HP1β (green) antibodies. DNA was counter stained with DAPI 
(blue). Control immunostaining was negative when performed with secondary antibody alone (data not shown). Bars in C represent 30 μm and bars in D 
show 8 μm.
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(Figure 2B, 0–2 hours, S473) and decreased thereafter
through G1 phase (Figure 2B). The lower panel of Figure
2B shows the level of phosphorylated TIF1β/Ser473 in
relation to that of total TIF1β at each time point. The M-
phase marker cyclin B or phosphorylated histone H3S10
identify specific stages of mitotic release (Figure 2B).
To further evaluate the phosphorylation state of TIF1β/
S473 from G1 to S phase, HeLa cells were serum starved
for three days to arrest in G1 phase. The level of phospho-
rylated TIF1β/Ser473 was almost non-detectable in G1
phase (Figure 2C, 0 hr, S473), reached a maximum 2
hours after serum was added and declined thereafter (Fig-
ure 2C, 2 hr, S473). The gradual increase in the level of
cyclin A or decrease in the level of cyclin B demonstrated
the specific cell cycle stage from G1 to S (Figure 2C). This
dynamic, biphasic (S and M phases) appearance of phos-
phorylated TIF1β/Ser473 suggests that TIF1β may be
involved in regulating the cell cycle by the switching on
and off of Ser473 phosphorylation.
Various cell cycle regulated proteins may exhibit changed
activity when phosphorylation modulates their stability.
The total protein level of TIF1β remained approximately
constant while the level of phosphorylated TIF1β/Ser473
fluctuated throughout the cell cycle. To further demon-
strate this dynamic fluctuation of phosphorylated TIF1β/
Ser473 level, HeLa cells were immunostained using S473
antibody. The level of phosphorylated TIF1β/Ser473 in
the cells 2 hr after serum addition markedly exceeded that
in the serum-starved cells (Figure 2C, immunofluores-
cence staining, compare early S and G1, S473). The pro-
tein level and distribution of TIF1β during G1 were the
same as those of early S phase (Figure 2C, immunofluo-
rescence staining, compare 20A1). Furthermore, in later
experiments using over-expressed FLAG-TIF1βs, similar
nuclear distribution patterns of over-expressed wild-type
FLAG-TIF1β, FLAG-TIF1β/S473A and FLAG-TIF1β/S473E
were observed (Figure 2D, compare M2). HP1β staining
also showed nuclear localization with over-expressed
FLAG-TIF1βs (Figure 2D, compare HP1β in transfected
cells).
As a well known corepressor, TIF1β regulates gene expres-
sion through direct binding to HP1 proteins in numerous
transcriptional-repressed loci. Thus, the immunostaining
data further indicate that TIF1β might control its co-regu-
lator function in the nuclear microenvironment via
Ser473 phosphorylation/dephosphorylation.
Phosphorylation of TIF1β/Ser473 compromises interaction 
between HP1β and TIF1β
The Ser473 is located close to the PXVXL (aa 486–490)-
containing HP1 box (aa 483–497) (Figure 3A). To eluci-
date the role of TIF1β in regulating gene expression, we
examined whether its interaction with HP1β was affected
by the phosphorylation of S473. Immunoprecipitation
and Western blotting experiments were performed using
293T cells that were co-transfected with FLAG-TIF1β
(TIF1β), FLAG-TIF1β/S473A (S473A) or FLAG-TIF1β/
S473E (S473E) and HA-HP1β. The interaction between
FLAG-TIF1β/S473A and HP1β was stronger than that
between FLAG-TIF1β/S473E or FLAG-TIF1β and HP1β
(Figure 3B). To demonstrate that the reduced phosphor-
ylation level of TIF1β/Ser473 was related to its stronger
interaction with HP1β, a pull-down assay was performed
using purified GST-HP1β from E. coli and FLAG-TIF1β,
FLAG-TIF1β/S473A or FLAG-TIF1β/S473E from 293T
cells. GST-HP1β interacted with non-phosphorylated-
mimetic FLAG-TIF1β/S473A 1.6 times more effectively
than with phosphorylated-mimetic FLAG-TIF1β/S473E
(Figure 3C). The similarity of the level of interaction
between wild-type FLAG-TIF1β and GST-HP1β and that of
FLAG-TIF1β/S473A and GST-HP1β (1.39 vs. 1.63) may
reflect a lower phosphorylation level of wild-type FLAG-
TIF1β here. To verify that TIF1β/Ser473 phosphorylation
compromises the interaction between TIF1β and HP1β,
M2 or HA antibody pull-down assays were conducted
using in vitro translated HA-HP1β and FLAG-TIF1β, FLAG-
TIF1β/S473A, or FLAG-TIF1β/S473E. The results of the
M2 pull-down and the HA antibody pull-down assay
indeed demonstrated that the interaction between HA-
HP1β and FLAG-TIF1β/S473A is much stronger than that
between FLAG-TIF1β/S473E and FLAG-TIF1β (Figure
3D). Taken together, these data demonstrate that the
phosphorylation state of TIF1β/Ser473 influences the
interaction between TIF1β and HP1β both in vivo and in
vitro. When TIF1β/Ser473 is phosphorylated, its interac-
tion with HP1β is compromised.
Although the TIF1β co-repressor function is known to be
related to HP1β, few studies have addressed the specific
gene targets of TIF1β. TIF1β/S473 phosphorylation is up-
regulated during the S phase in HeLa cells and the interac-
tion between HP1β and TIF1β is compromised when
Ser473 is phosphorylated. These observations suggest that
the phosphorylation of TIF1β/Ser473 may regulate gene
expression by abolishing its interaction with HP1β.
TIF1β regulates key genes expression during G1 to S-phase 
cell cycle progression
Chromatin immunoprecipitation (ChIP) experiments
were used to study the possible involvement of Ser473-
phosphorylated/dephosphorylated TIF1β in the expres-
sion of HeLa cell cycle-specific genes during the transition
from G1 phase to S phase. TIF1β/phospho-Ser473 was
almost undetectable in the G1 phase, and climbed there-
after to reach maximum level in early S phase. As Cyclin A2
is known to be expressed in early S phase but not in G1Page 5 of 16
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Interaction between TIF1β and HP1β is compromised by phosphorylation of TIF1β/Ser473Figure 3
Interaction between TIF1β and HP1β is compromised by phosphorylation of TIF1β/Ser473. (A) Schematic repre-
sentation of domain organization of TIF1β protein. The position of Ser473 relative to the PXVXL motif is shown. (B) Western 
blot results of co-immunoprecipitation of over-expressed FLAG-TIF1β and HA-HP1β. FLAG-TIF1β/S473A, FLAG-TIF1β/S473E 
and wild-type FLAG-TIF1β were co-expressed with HA-HP1β into 293T cells. The level of ectopically expressed FLAG-TIF1βs 
(Input, M2) or M2-beads immunoprecipitated FLAG-TIF1βs (M2-IP, M2) was probed with M2 antibodies (TIF1β, M2). The level 
of ectopically expressed HA-HP1β (Input, HA) or M2-beads co-immunoprecipitated HA-HP1βs (M2-IP, HA) was probed with 
monoclonal anti-HA antibodies (HP1β, HA). (C) In vitro GST pull-down assay of TIF1βs by recombinant GST-HP1β. Wild-type 
and mutant FLAG-TIF1βs were expressed in 293T cells. These FLAG-TIF1βs were immunoprecipitated by M2 beads and 
eluted with M2 peptide. The levels of FLAG-TIF1βs from 1/10 input for each pull down assay were shown (lanes 8–10). Eluted 
FLAG-TIF1βs were incubated with GST-beads alone (lanes 1–3) or incubated with recombinant GST-HP1β bound glutathione-
beads (lanes 4–6). The levels of GST-HP1β and FLAG-TIF1βs in each pull down assay were shown (lanes 1–6). Quantitation of 
the Western blots (by ImageGauge software) from each pull down sample (lanes 4–6) showing the relative level of FLAG-
TIF1βs (A, TIF1β/S473A; E, TIF1β/S473E; W, wild-type TIF1β) pulled down by GST-HP1β, after normalization to individual 
GST-HP1β levels (right panel). (D) Interaction between in vitro translated FLAG-TIF1βs and HA-HP1β. Upper panel, In vitro 
translated [35S] FLAG-TIF1βs and [35S]-HA-HP1β were incubated for 30 min before being immunoprecipitated by M2 beads in 
the presence of 0.5 M NaCl. The immunoprecipitates were resolved by SDS-PAGE and followed by autoradiography to visual-
ize HA-HP1β (upper right panel, M2-pull down). Lower panel, In vitro translated [35S] FLAG-TIF1βs and [35S] HA-HP1β were 
pulled down by protein-G coupled anti-HA antibody. The immunoprecipitated FLAG-TIF1βs are shown in the lower right 
panel (TIF1βs, IP). Supernatants after immunoprecipitation are also shown, as indicated (S).
BMC Molecular Biology 2008, 9:61 http://www.biomedcentral.com/1471-2199/9/61phase, a reasonable question arises: Is the TIF1β/Ser473
phosphorylation correlated with cyclin A2's expression?
PCR primers encompassing the E2F site were used to
detect DNA fragments corresponding to the promoter
region of cyclin A2. A much higher level of TIF1β was asso-
ciated with the cyclin A2 promoter at the G1/S boundary
than in early S phase (Figure 4A, upper panel). These
results are closely correlated with the rise in phosphor-
ylated TIF1β/Ser473 in the early S phase, but not at the
G1/S boundary (Figure 4A, lower left panel). Histone H3
TIF1β is involved in the regulation of expression of E2F downstream genes, cyclin A2, Cdc2 and Cdc25AFigure 4
TIF1β is involved in the regulation of expression of E2F downstream genes, cyclin A2, Cdc2 and Cdc25A. (A) Binding of TIF1β to the promoter of cyclin A2 gene is 
correlated with its repression. HeLa cells were synchronized to G1/S boundary by double thymidine block and subsequently released for 1 hour to the early S phase. ChIP was 
performed as described in the Materials and Methods section. Equal loadings of input derived from G1/S and S cells were used for ChIP experiments (upper panels), using 20A1, 
H3K4diMe, and H3K9diMe antibodies. PCR was performed with input samples (1/50) and ChIP eluates. Relative differences between G1/S and S phase of each indicated probe 
on cyclin A2 promoter are shown in the lower right panels (comparing the cyclin A2 signal of G1/S and S phase from each probe with the same total area, by ImageGauge soft-
ware). The protein level of TIF1β (20A1), α-tubulin and phosphorylated TIF1β/Ser473 (S473) from formaldehyde cross-linked samples are shown in the lower left panel. PCR for 
cyclin E promoter was used as a control (upper panel). (B) HeLa cells were arrested at G1 phase by serum starvation and released into early S phase by addition of serum to the 
culture for 2 hours. ChIP was performed as in (A) with 20A1, anti-H3K4diMe and anti-H3K9diMe antibodies (upper panel). Relative differences between G1 and S phase of each 
indicated probe on cyclin A2 promoter are shown in the lower right panels (by ImageGauge, as in A), while the protein levels are shown in the lower left panel. (C) Flow cytom-
etry analysis. FLAG-TIF1β/S473A, FLAG-TIF1β/S473E and wild-type FLAG-TIF1β were over-expressed in 293T cells, collected 36 hours post-transfection and analyzed by flow 
cytometry after staining with propidium iodide, and the FCM histograms are shown in the upper panels. Cell cycle phase distributions (%) of TIF1β over-expressing cells were 
analyzed with the CellQuest software and shown in the lower left panel, according to the gated region from the upper panel (M1, subG1; M2, G1; M3, S; and M4, G2/M, by Cel-
lQuest program), and the bar charts represented the cell cycle distribution (in total for 100%) are shown in the lower right panel (by Microsoft Excel). (D) The HP1β complex 
is preferentially associated with the promoters of Cdc2 and Cdc25A in TIF1β/S473A over-expressing interphase cells of HEK293T. FLAG-TIF1β, FLAG-TIF1β/S473A, FLAG-
TIF1β/S473E and HA-HP-1β were ectopically expressed in HEK 293T cells for 36 hours and subjected to ChIP with the indicated antibodies (anti-tubulin, 10D8; anti-TIF1β, 
20A1; anti-HA, HA). DNA from the immunoprecipitated chromatin was quantified by real-time PCR. Each result was normalized to input and the relative level to the transfected 
vector control. Results for the Cdc2 promoter (upper panels) and Cdc25A promoter (lower panels) are shown.Page 7 of 16
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sion. The ChIP results demonstrated that the level of
H3K9diMe correlated strongly with that of TIF1β. How-
ever, histone H3K4diMe is known to associate with
actively transcribed genes. Its association with the pro-
moter region of cyclin A2 was inversely correlated with
that of TIF1β. Quantitative ChIP results comparing the
cyclin A2 level in G1/S and S phase are presented under the
panel of PCR results obtained using each probe. As a con-
trol, TIF1β was not associated with the promoter of cyclin
E (Figure 4A, upper panel). TIF1β/phospho-Ser473 was
also elevated 2 hours after serum was added (Figure 2C).
ChIP was thus used to measure the level of TIF1β bound
to the cyclin A2 promoter in G1-phase HeLa cells that had
been starved of serum for three days or S-phase HeLa cells
that had been released from serum starvation. More TIF1β
in the G1 phase cells was associated with the promoter
region of cyclin A2 (Figure 4B, upper panel). This finding
is closely correlated with the elevated level of phosphor-
ylated TIF1β/Ser473 in the S phase but not in the G1
phase (Figure 4B, lower left panel). Quantitative ChIP
results, comparing cyclin A2 levels in the G1 and S phase,
are presented beneath the PCR results obtained using each
probe. Taken together, these results indicate that the asso-
ciation of TIF1β with the promoter of cyclin A2 is corre-
lated with silencing while dissociation is correlated with
derepression of the promoter.
Immunostaining showed that over-expression of FLAG-
TIF1β, FLAG-TIF1β/S473A, and FLAG-TIF1β/S473E did
not alter their nuclear localization (Figure 2D). A flow
cytometric analysis was performed to test further the
effects of over-expressed FLAG-TIF1β, FLAG-TIF1β/S473A
and FLAG-TIF1β/S473E on cell cycle progression. Over-
expression of the FLAG-TIF1β/S473A mutant caused an
accumulation of cells stalled at G2/M in 293T cells (Figure
4C), while the profiles of cell cycle progression were sim-
ilar in 293T cells over-expressing FLAG-TIF1β and FLAG-
TIF1β/S437E, suggesting that the phosphorylation state of
TIF1β/Ser473 affects cell cycle progression. Quantitative
real-time PCR analysis of 293T cells revealed half the
amount of cyclin A2 mRNA in the FLAG-TIF1β/S473A-
overexpressing cells compared to the FALG-TIF1β or
FALG-TIF1β/S473E-expressing cells (data not shown).
The phenotype of the G2/M stalls and the reduction of the
cyclin A2 mRNA level in TIF1β/S473A over-expressing
293T cells are consistent with observations made in a
GFP-cyclin A2 siRNA knockdown experiment published
by Kenrick et al. [29]. Taken together, these results suggest
that disruption of TIF1β/Ser473 phosphorylation may
influence cell cycle-regulated gene expression, and that
cyclin A2 may be one of the TIF1β indirect target genes.
These data also demonstrate that the Ser473 phosphoryla-
tion/dephosphorylation status of TIF1β may regulate cell
cycle progression.
To further examine the association of unphosphorylated
TIF1β/Ser473 with other cell cycle-regulated genes, such
as Cdc2 and Cdc25A, quantitative ChIP experiments were
conducted with HEK293T cells that had been transfected
with HA-HP1β and FLAG-TIF1β, FLAG-TIF1β/Ser473A,
and FLAG-TIF1β/Ser473E. When ChIP was performed
with HA monoclonal antibody, the association of HP1β
with the promoters of Cdc2 or Cdc25A in FLAG-TIF1β/
Ser473A over-expressing cells was stronger than in FLAG-
TIF1β/Ser473E-over-expressing cells (Figure 4D). When
ChIP was performed using 20A1 (which recognizes the N-
terminal of TIF1β), no obvious difference between FLAG-
TIF1β/Ser473A and FLAG-TIF1β/Ser473E was observed.
Collectively, these results reveal that over-expressed HP1β
and TIF1β/Ser473A may form a stronger complex and
preferentially associate with the promoter regions of Cdc2
and Cdc25A genes more than over-expressed HP1β and
TIF1β/Ser473E in interphase HEK293T cells.
Phosphorylation of TIF1β Ser473 in S phase is mediated by 
PKC pathway
TIF1β/Ser473 phosphorylation is up-regulated in S phase.
To identify which kinase(s) are involved in the phospho-
rylation of TIF1β/Ser473 in the S phase, we used Western
blotting of cell extracts prepared from cells that had been
treated with a panel of kinase inhibitors. Among the
inhibitors tested, only the PKC inhibitor (Ro-31-8820)
exhibited significant inhibition, while the CK1 inhibitor
had a moderate effect on the phosphorylation of Ser473
(Figure 5A). An inhibitory peptide (a substrate-mimetic
fragment from aa 466–478 of TIF1β) that contained
TIF1β/S471A/S473A also blocked TIF1β/Ser473 phos-
phorylation (data not shown). Neither CaMK-II inhibitor
nor staurosporine had any effect (Figure 5A). To confirm
that the phosphorylation of TIF1β/Ser473 proceeds along
the PKC pathway, the effect of 12-O-tetradecanoylphor-
bol-13-acetate (TPA) on TIF1β/Ser473 phosphorylation
in interphase HeLa cells was tested. TPA treatment
induced dramatic phosphorylation of TIF1β/Ser473
within 1 hour (Figure 5B). To further examine whether
subtype-PKCδ is involved in the phosphorylation of
TIF1β/Ser473, M2-immunoprecipitation and Western
blotting with S473 antibody were performed using cell
extracts that were prepared from FLAG-TIF1β and HA-
PKCδ-cotransfected 293T cells. The phosphorylation level
of TIF1β/Ser473 was double that of the control (Figure
5C). Immunostaining also revealed an increase of the
TIF1β/Phospho-Ser473 signal in HA-PKCδ-transfected
HeLa cells (Figure 5D). Although the majority of over-
expressed PKCδ was located in the cytoplasm, a minor
portion appeared in the nucleus (Figure 5D, column 3).
Collectively, these results indicate that TIF1β/Ser473
phosphorylation in S phase could be mediated by the
PKCδ pathway, and that TIF1β/Ser473 phosphorylation
correlated with the expression of target genes by weaken-Page 8 of 16
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PKC is involved in the phosphorylation of TIF1β/Ser473 in early S phaseFigure 5
PKC is involved in the phosphorylation of TIF1β/Ser473 in early S phase. (A) HeLa cells were synchronized with double thymidine block at G1/S phase and treated 
with various kinase inhibitors before being released for 1 hour to early S-phase (experimental procedures are depicted in the bottom scheme). Lanes 1–6, Western blot of 
whole cell extracts of cells arrested at G1/S boundary. Lanes 7–12, Western blot of early S-phase extracts. The inhibitors used were CaMK-II inhibitor KN93 (KN, 1 μM), PKC 
inhibitor Ro-31-8220 (Ro, 100 nM), CK1 inhibitor D4476 (CK-I, 10 μM,), staurosporin (St, 20 nM), and DMSO as a control. The levels of TIF1β (20A1), phosphorylated TIF1β/
Ser473 (S473) and α-tubulin are shown. Quantitative results of the Western blots in early S phase (by ImageGauge software) showing the relative TIF1β/Ser473 phosphorylation 
level in various kinase inhibitor treatment, after normalization to individual TIF1β level. (B) Phosphorylated TIF1β/Ser473 was highly elevated in TPA-treated HeLa cells. Inter-
phase HeLa cells were treated with 100 ng/ml or 250 ng/ml TPA for 1 hour, and whole cell extracts were prepared for Western blot. (C) Phosphorylation of TIF1β/Ser473 in 
293T cells was highly induced by over-expressed HA-PKCδ. 293T cells were cotransfected with 1 μg of FLAG-TIF1β plasmid and HA-PKCδ plasmids (1 or 2 μg). FLAG-TIF1β 
was immunoprecipitated by M2-beads 36 hours post-transfection and probed with antibody to phosphorylated TIF1β/Ser473. Quantitative results (by ImageGauge software) 
show the relative TIF1β/S473 phosphorylation level in the presence of various amounts of transfected PKCδ plasmid, after normalization to individual TIF1β level. (D) Phospho-
rylation of TIF1β/Ser473 was specifically increased in HA-PKCδ transfected HeLa cells. HA-PKCδ transfected HeLa cells were fixed 36 hours post-transfection and co-stained 
with monoclonal anti-HA antibody (red) and TIF1β/S473 antibody (green). DNA was visualized by counter staining with DAPI (blue). Different maginification of images are 
shown in columns 1–3. The localization of HA-PKCδ or TIF1β in the nucleus is indicated (column 3, arrow). Bars in D represent: column 1, 40 μm; column 2, 20 μm; and column 
3, 7 μm.
BMC Molecular Biology 2008, 9:61 http://www.biomedcentral.com/1471-2199/9/61ing TIF1β/HP1β interaction (and heterochromatin forma-
tion).
Level of phosphorylated TIF1β/Ser473 is reduced in 
megakaryocytic differentiated K562 cells
TIF1β/Ser473 phosphorylation fluctuates during cell cycle
progression. K562 cells were used as an inducible cell dif-
ferentiation system to profile the level of phosphorylated
TIF1β/Ser473 in both proliferating and differentiated
cells. K562 is an erythroleukemic cell line that can
undergo further differentiation in both megakaryocytic
and erythroid lineages, depending on the stimulus
[30,31]. It is a well-characterized system in which TPA
stimulates the megakaryocytic development of K562.
Western blotting was performed on extracts prepared
from proliferating or TPA-induced differentiated K562
cells. The differentiated K562 cells exhibited megakaryo-
cytic morphology (with lobulated nucleus, highly vacu-
olated, and histiocytoid), as demonstrated by phase
contrast images (Figure 6). Although the total TIF1β pro-
tein level in differentiated K562 cells was lower than that
in proliferating cells (Figure 6, CB stain and Western blot),
the level of phosphorylated TIF1β/Ser473 was halved in
megakaryocytic differentiated K562. Consistent with the
observation that TIF1β promotes cell cycle progression by
the up-regulation of its Ser473 phosphorylation, the
amount of TIF1β/Ser473 phosphorylation may be utilized
as a proliferation marker in cancer cells.
Discussion
This investigation demonstrates that the phosphorylation
of TIF1β/Ser473 by kinase(s) (such as PKCδ) may act as a
molecular switch in the temporal regulation of gene
expression. TIF1β/Ser473 is located close to the HP1 box,
the PXVXL motif, which is responsible for the interaction
between TIF1β and HP1, and its phosphorylation nega-
tively affects this interaction. The dynamic phosphoryla-
tion of TIF1β/Ser473 suggests that this event may regulate
the functions of TIF1β in cell cycle progression. The cen-
tral question then is: How may the phosphorylation of
TIF1β/Ser473 regulate TIF1β-mediated gene expression?
We addressed this question by investigating the potential
regulatory functions of TIF1β on key genes for cell cycle
pregression and the effects of over-expressing phosphor-
ylation-deficient or phosphomimetic mutants of TIF1β/
Ser473 on cell cycle progression. TIF1β is proposed to
function as a universal corepressor protein for the KRAB
zinc finger protein (KRAB-zfp) superfamily of transcrip-
tional repressors [32]. The recruitment of HP1 proteins by
the KRAB-TIF1β complex to specific loci within the
genome through the formation of heterochromatin-like
complexes may silence gene activity.
The phosphorylation of TIF1β/S473 compromises its 
interaction with HP1β in a manner that is related to cell 
cycle-regulated gene expression
The disruption of the interaction between HP1β and
TIF1β by the phosphorylation of TIF1β/Ser473 (Figure 3)
suggests that this phosphorylation/dephosphorylation of
TIF1β/Ser473 may be the means of regulation of TIF1β-
and HP1β-mediated gene silencing. The results of ChIP
experiments suggest that the majority of TIF1β associated
with the promoters of cyclin A2 in G1 phase cells is likely
to be unphosphorylated TIF1β/Ser473. This conclusion is
supported by two lines of evidence: (1) very low levels of
phosphorylated TIF1β/Ser473 were observed in G1 cells,
and (2) overexpressed FLAG-TIF1β/S473A bound to the
promoters of Cdc2 and Cdc25A better than FLAG-TIF1β/
S473E. When cells were released into the S phase, the
association of unphosphorylated TIF1β/Ser473 with these
promoters decreased, accompanying an increased level of
phosphorylated TIF1β/Ser473. The dynamics of TIF1β/
Ser473 phosphorylation and TIF1β-binding to the cyclin
A2 promoter (during the G1 to S phase progression) indi-
cate that un-phosphorylated TIF1β/Ser473 is responsible
for silencing the cyclin A2 gene in the G1 phase (Figures 4A
The level of phosphorylated TIF1β/Ser473 is decreased in PA-induced differentiated K562 cellsFigure 6
The level of phosphorylated TIF1β/Ser473 is 
decreased in TPA-induced differentiated K562 cells. 
K562 cells were treated with 10 ng/ml TPA for 4 days. Phase 
contrast images of control (left panels, TPA-) and differenti-
ated (right panels, TPA+) K562 cells are shown. Equal 
amounts of proteins from these cells were collected 
(Coomassie Blue stain) and TIF1β (20A1) or phosphorylated 
TIF1β/S473 (S473) were detected by Western hybridization. 
The relative TIF1β/S473 level of proliferating or TPA-induced 
differentiated K562 cells (by ImageGauge software, after nor-
malization to individual TIF1β level) is shown. Bars in phase 
contrast images represent 40 μm (upper panels) and 8 μm 
(lower panels).Page 10 of 16
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with un-phosphorylated TIF1β/Ser473 is consistent with
the ChIP results concerning the over-expressed recom-
binant variants, where over-expressed FLAG-TIF1β/S473A
associated better with the promoter region of Cdc2 or
Cdc25A than that did FLAG-TIF1β/S473E (Figure 4D).
The treatment of cells with cyclin A2 siRNA led to an accu-
mulation of cells in prophase and mitosis to a degree sim-
ilar to that observed for cyclin B1, consistent with the
requirement of cyclin A for G1/S and G2/M transitions
[29]. Interestingly, the ChIP results (Figures 4A and 4B)
and the effects of over-expressed FLAG-TIF1β/Ser473A on
cell cycle progression (accumulation of G2/M cells, Figure
4C) are consistent with published results for the siRNA
knockdown of Cyclin A2 [29].
HP1β recruitment to E2F-binding element of Cdc2 and
Cdc25A promoters was affected by the phosphorylation
state of TIF1β/Ser473. The level of HP1β recruitment to
Cdc2 or Cdc25A promoter was increased when wild-type
FLAG-TIF1β or FLAG-TIF1β/S473A were ectopically
expressed. This association was compromised by the
phosphomimetic mutant, S473E, which suggests that
HP1β recruitment is negatively regulated by phosphoryla-
tion of TIF1β/Ser473. Likewise, ectopically expressed
HP1β resulted in elevated recruitment of wild-type FLAG-
TIF1β or FLAG-TIF1β/S473A. These observations provide
a clue that the recruitment of TIF1β and HP1β could work
in a positive feedback manner.
The above results demonstrate that the dynamic intercon-
version between unphosphorylated and phosphorylated
forms of TIF1β/Ser473 may be crucial in the regulation of
gene expression during cell cycle progression. Despite
extensive efforts to perform ChIP with rabbit anti-phos-
phorylated TIF1β/Ser473 antibody, no significant result
was obtained. A likely explanation of this failure is that
phosphorylated TIF1β/Ser473 is not associated with the
promoter of cyclin A2 in the G1 phase or, alternatively, the
epitope in the multiprotein complex is masked from anti-
body access.
The way in which TIF1β disassociates from the HP1-con-
taining heterochromatin is unclear. However, the findings
herein provide a molecular explanation, which involves
PKC-mediated phosphorylation at TIF1β/Ser473 (Figure
5).
Phosphorylated TIF1β/S473 level may serve as a 
proliferation marker
TIF1β transcriptional repression activity depends on the
interaction between TIF1β and HP1β [11]. This interac-
tion is essential to the relocation of TIF1β from euchroma-
tin to heterochromatin that accompanies the
differentiation of primitive endoderm-like cells [12].
TIF1β is known to interact differentially with HP1β and
HP1γ in differentiated and non-differentiated cells [33].
In non-differentiated cells, TIF1β/HP1 interaction occurs
only in euchromatin and selectively involves HP1β and
HP1γ, but not HP1α. In differentiated cells, on the other
hand, TIF1β selectively associates with HP1β in hetero-
chromatin, while TIF1β and HP1γ interaction occurs only
in euchromatin. These conclusions agree with the reduced
level of phosphorylated TIF1β/Ser473 seen here in differ-
entiated K562 cells (Figure 6). The results herein also
revealed that un-phosphorylated TIF1β/Ser473 interacts
more strongly with HP1β than its phosphorylated coun-
terpart (Figure 4B). These results further suggest that the
phosphorylation of TIF1β/Ser473 regulates the differen-
tial interaction between TIF1β and HP1β.
What may be the functional consequences of the phos-
phorylation of TIF1β/Ser473 and its consequent dissocia-
tion from HP1s must be addressed. TIF1β interacts with
E2F [16], TRIP-Br and CBP/p300, and potentiates the co-
activation of E2F-1/DP-1 by TRIP-Br protein [34]. Phos-
phorylated TIF1β/Ser473 may thus be involved in this tri-
partite functional interaction. This suggestion is
supported by our findings that the induction of cyclin A2
is accompanied by an increased level of phosphorylated
TIF1β/Ser473 and reduced binding of TIF1β to the pro-
moter. A most provocative question that remains to be
answered is whether the Ser473-phosphorylated TIF1β
may interact preferentially with transcription factors and
serve as a coactivator.
The results also demonstrated that the level of phosphor-
ylated TIF1β/Ser473 peaks at early S- and M-phases. Two
phosphorylation sites other than Ser473, Ser752 and
Ser757, were also identified in the course of this investiga-
tion. Both sites are located in the bromodomain of TIF1β.
The phosphorylation-deficient or phosphomimetic
mutants of Ser757 did not influence the phosphorylation
of Ser473 (Chang, unpublished results), suggesting that
these phosphorylations may be independent events dur-
ing mitosis. Other phosphorylation sites important for
regulating the function of TIF1β have also been identified
[35]. The functional consequences of Ser752 and Ser757
phosphorylation remain to be investigated.
PKC mediated TIF1β/S473 phosphorylation may be 
involved in cell cycle progression
Numerous examples have demonstrated that PKCδ is cen-
trally involved in cell proliferation and differentiation.
The activation of PKCδ uniquely mediates insulin-
induced proliferation: PKCδ is activated by insulin and
interacts with insulin receptor and IRS [36-38]. Insulin-
activated PKCδ interacts with 3-phosphoinositide-
dependent protein kinase to regulate Protein Kinase BPage 11 of 16
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cyte proliferation [40]. Although the over-expressed PKCδ
is mainly located in the cytoplasm (Figure 5D), it has been
shown here (Figure 5D) and by Kajimoto et al. to partially
localize to the nucleus [41]. The observation herein that
the serum-stimulated phosphorylation of TIF1β/Ser473
correlates strongly with G1/S progression and cyclin A2
expression (Figure 4) uncovers a novel mechanism of
PKCδ-mediated G1 to S phase cell cycle progression.
Phosphorylation of TIF1β/Ser473, gene activation and 
stem cell proliferation
The dynamic phosphorylation of TIF1β/Ser473 during
cell proliferation and differentiation (Figures 2 and 6)
suggests that phosphorylation/dephosphorylation is cru-
cial for regulating the transcriptional activity of TIF1β.
During the differentiation of embryonic carcinoma cells,
the intracellular distribution of TIF1β changes from dif-
fuse nuclear staining to discrete foci and colocalizes with
heterochromatin [42]. The steady-state level of TIF1β is
also decreased. The reduced levels of phosphorylated
TIF1β/Ser473 as well as the lower steady-state TIF1β levels
in differentiated cells suggest that TIF1β may be mainly
localized to heterochromatin in differentiated cells. In
embryonic stem cells, TIF1β is present in complexes with
various pluripotent markers, including Rex-1, Dax-1 and
Nanog [22]. Since phosphorylated TIF1β/Ser473 seems to
be preferentially associated with cell proliferation, it is
important to determine whether it resides in these com-
plexes. In fact, the level of phosphorylated TIF1β/Ser473
may serve as a proliferation marker. The epigenetic silenc-
ing of retrovirus transcription is caused by the binding of
a TIF1β corepressor complex to retrovirus primer binding
site [17]. The likely recruitment of TIF1β by a DNA-bind-
ing KRAB-box containing zinc finger protein for PBS-
mediated silencing should be addressed, and the question
of whether the regulation of the phosphorylation of
TIF1β/Ser473 or the formation of TIF1β corepressor com-
plex is participating in retrovirus transcription should also
be investigated.
Conclusion
Although the TIF1β co-repressor function is known to be
related to HP1β, few studies have addressed the specific
gene targets of TIF1β. We have found that cell cycle pro-
gression is regulated by TIF1β. The key cell cycle regula-
tory genes, Cyclin A2, Cdc2 and Cdc25A are targeted by
TIF1β, and phosphorylation of TIF1β/Ser473 is associated
with the activation of these genes. TIF1β/S473 phosphor-
ylation is up-regulated during the S phase in HeLa cells
and the interaction between HP1β and TIF1β is compro-
mised when Ser473 is phosphorylated. These observa-
tions suggest that the phosphorylation of TIF1β/Ser473
may regulate gene expression by abolishing its interaction
with HP1β. Thus, phosphorylation of TIF1β/Ser473 plays
a crucial role in epigenetic regulation of gene expression.
Methods
Antibodies
Monoclonal antibody against TIF1β was generated by
immunizing BALB/c mice with recombinant TIF1β corre-
sponding to the N-terminal region (amino acids 1–250).
Clone 20A1 was used throughout this investigation. Phos-
pho-specific polyclonal antibody (S473) was produced by
immunizing rabbits with KLH-conjugated peptide
(VKRSRpSGEGEVC). The S473 antibody was purified by
peptide-agarose affinity column chromatography. Rabbit
anti-H3K9diMe and H3K4diMe antibodies were obtained
from Upstate/Millipore, cyclin A and cyclin B antibodies
were from BD Science, and M2 monoclonal antibody and
M2 beads were from Sigma.
Plasmids and chemicals
Mouse pCMV-FLAG-TIF1β was cloned as described by
Chang et al. [43]. Site-directed mutagenesis was per-
formed using pCMV-FLAG-TIF1β to create S473A and
S473E mutants with PfuTurbo DNA Polymerase (Strata-
gene). The primers, based on nucleotides 1691 to 1721 of






HA-PKCδ was obtained from Dr. C. K. Chou, HA-HP1β
and GST-HP1β plasmids were kindly provided by Dr.
Pierre Chambon. PKC inhibitor Ro-31-8820 and calcium/
calmodulin-dependent protein kinase-II (CaMK-II) inhib-
itor KN-93 were from BIOMOL. Casein kinase1 (CK1)
inhibitor D4476 was from Calbiochem. Staurosporin, 12-
O-tetradecanoylphorbol-13-acetate (TPA), thymidine,
and nocodazole were from Sigma. Ser473-specific inhibi-
tory peptide SGVKRARAGEGEVrrrrrrrrr (r stands for
arginine) was obtained from Genemed Synthesis (South
San Francisco, CA).
Cell cultures
HeLa, HEK293, and HEK293T cells were cultured in Dul-
becco's modified Eagle's medium plus 10% FCS and 100
units/ml penicillin/streptomycin. For synchronization at
mitotic phase, HeLa cells were treated with 1 μM nocoda-
zole for 16 hours. Cells were collected by shake-off, rinsed
with PBS and cultured in complete medium. For synchro-Page 12 of 16
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mM thymidine for 19 hours, released for 10 hours, treated
for 19 hours again before release at various time points for
cell cycle progression. For G1 phase synchronization,
HeLa cells were serum-starved for 72 hours and then cul-
tured in complete medium for various times. K562 cells
were maintained in RPMI-1640 with 10% FCS and 100
units penicillin/streptomycin. K562 cells were induced to
differentiate by treating with TPA (10 ng/ml) for 4 days
[30,31].
Whole cell extracts (WCEs) were prepared by treating the
cells with lysis buffer [20 mM HEPES, pH 7.4, 200 mM
NaCl, 0.5% Triton-X100, 20% glycerol, 1 mM EDTA, 1
mM EGTA, 1 mM orthovanadate, and protease inhibitors
(0.1 μg/ml each of aprotinin, leupeptin, pepstatin A, and
10 mM PMSF) and centrifuging at 6,000 × g in a microcen-
trifuge for 30 min at 4°C. Nuclear fractions were prepared
by lysing the cells in HEPES buffer (pH 7.6) containing 10
mM NaCl, 1.5 mM MgCl2, 20% glycerol, 0.2 mM EDTA,
0.1% Triton X-100 and protease inhibitors for 10 min,
centrifuged at 1,250 × g for 5 min and washed once with
the same buffer. Nuclear extracts were prepared in nuclear
extraction buffer containing 25 mM Tris-HCl, pH 8.0, 0.5
M NaCl, 1 mM EDTA, 10% glycerol, 0.2% NP-40 and pro-
tease inhibitors for 30 min at 4°C followed by DNase I
treatment for 1 hour. For calf intestine alkaline phos-
phatase (CIP) treatment, 293 T cells were lysed with CIP
buffer (50 mM Tris-HCl, pH 8.0, 0.1 M NaCl, 10 mM
MgCl2, and protease inhibitors). The supernatants were
incubated with 30 U of CIP at 37°C for 30 min.
Immunoprecipitation, recombinant proteins, in vitro pull-
down, and western blotting
WCE was pre-cleaned with protein G beads. Antibody was
bound to protein G beads and mixed with pre-cleaned
WCE for 2 hours at 4°C by gentle rotation. The immuno-
complex was washed 3 times with immunoprecipitation
buffer before SDS sample buffer was added and proteins
were separated by SDS-PAGE. TIF1βs (FLAG-TIF1β/
S473A, FLAG-TIF1β/S473E, and wild type FLAG-TIF1β)
were co-transfected with HA-HA-HP1β into 293T cells.
Nuclear extracts were used for M2 pull-down assay. GST-
HP1β expressed in Escherichia coli DH5α was purified by
binding to glutathione beads. FLAG-tagged TIF1β, TIF1β/
S473A and TIF1β/S473E were expressed in 293T cells and
purified by FLAG peptide elution of the M2 bead-bound
proteins. For pull-down assays, glutathione bead-bound
GST-HP1β was re-suspended in nuclear extraction buffer
and incubated with the purified FLAG-TIF1β, FLAG-
TIF1β/S473A, and FLAG-TIF1β/S473E.
In vitro transcription and translation
[35S]Methionine-labeled FLAG-TIF1βs (FLAG-TIF1β,
FLAG-TIF1β/S473A, and FLAG-TIF1β/S473E) and HA-
HP1β were prepared by TnT in vitro transcription/transla-
tion kit (Promega).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were per-
formed as described by Li et al. [44]. Briefly, synchronized
G1, G1/S, early S phase, or interphase cells were treated
with 1.42% of formaldehyde for 10 min at room temper-
ature. Nuclei from 1 × 107 cells were resuspended in ChIP
lysis buffer (50 mM Tris-HCl [pH 8.1], 1% SDS, 10 mM
EDTA, 1× protease inhibitor cocktail) and used for each
immunoprecipitation. After sonication on ice four to six
times for 10 seconds followed by centrifugation for 10
min, the chromatin solution was diluted 10-fold with
dilution buffer (5 μg/ml of salmon sperm DNA, 5 mg/ml
BSA, 20 mM Tris-HCl [pH 8.1], 1% Triton X-100, 2 mM
EDTA, 150 mM NaCl, 1× protease inhibitor cocktail). An
input control of 100 μl of sonicated solution was saved
and processed in parallel with the eluted immunoprecip-
itates beginning at the cross-link reversal step. The chro-
matin was pre-cleaned with protein G-agarose. Different
antibodies (TIF1β monoclonal antibody, 20A1; rabbit
anti-H3K9diMe and H3K4diMe antibodies) were bound
to protein G-agarose first in dilution buffer containing 5
μg/ml of salmon sperm DNA and 5 mg/ml BSA. Chroma-
tin complexes were then incubated with specific antibod-
ies-protein G-agarose and rotated for 2–4 hours at 4°C.
Immunoprecipitates were sequentially washed for 5 to 10
min in wash buffer I (20 mM Tris-HCl [pH 8.1], 2 mM
EDTA, 0.1% SDS, 1% Triton X-100, 150 mM NaCl), wash
buffer II (20 mM Tris-HCl [pH 8.1], 2 mM EDTA, 0.1%
SDS, 1% Triton X-100, 500 mM NaCl), wash buffer III
(0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA,
10 mM Tris-HCl [pH 8.1]), and then in TE buffer (three
times). Washed beads were incubated at 65°C overnight
to reverse protein-DNA cross-linking, and then each sam-
ple was treated with 10 μg of proteinase K in proteinase K
buffer for 6 h at 55°C. The eluted material was combined
in one tube, and the DNA was purified with the QIAquick
PCR purification kit (Qiagen, Valencia, Calif.28104) and
eluted in 50 μl of elution buffer. Extracted total inputs
were diluted 1:50 and subjected to PCR analysis with indi-
cated primers. Each PCR mixture contained 2 μl of immu-
noprecipitate or input, 1 μM each primer, 0.4 mM
deoxynucleoside triphosphate mixture, 1× LA-Taq PCR
buffer, and 0.25 μl LA-TaqDNA polymerase in a total vol-
ume of 50 μl. The E2F responsive primers for each pro-
moter were as follows:
For Cyclin A2 promoter:
Forward: 5'-CTGCTCAGTTTCCTTTGGTTTACC-3';
Reverse: 5'-CAAAGACGCCCAGAGATGCAG-3';Page 13 of 16
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Forward: 5'-GCCGCCTGTCCATTCATCC-3';
Reverse: 5'-GGTCCTGTGGAGCCTGTAGCC-3'.
PCR was performed for 26 to 29 cycles with 1 min of
denaturing at 94°C, annealing at 62°C, and extension at
68°C. PCR results were analyzed by agarose gel (1.5%)
electrophoresis.
For real time PCR, 5 μg of FLAG-TIF1β and HA-HP-1β
expression vectors were transfected into HEK 293T cells in
10-cm dish at about 20% confluence. In each precipita-
tion, 300 μg of total cell extract was used, with 50 μg of
total cell extract as input. Antibodies for FLAG (M2) or HA
were used to probe recombinant TIF1β and HP1β on E2F
targets of Cdc2 and Cdc25A promoters. Real-time PCR was
conducted on a Roche Light Cycler 480 using the follow-
ing primers for Cdc2 promoter:
Forward: 5'-ACAGTAGGACGACACTC-3'; and
Reverse: 5'-GGATTCACCAATCGGGTAG-3';




Cells on cover slips were washed with 1× phosphate-buff-
ered saline (PBS), fixed with 2% formaldehyde for 15
min, washed with cold PBS for three times and further
permeablized with 1xPBS containing 0.5% Triton-X100
for 5 min. Cells were blocked with 1% BSA for 30 min and
incubated with indicated antibodies diluted in 1% bovine
serum albumin/PBS, and probed with indicated primary
antibodies. Alexa 594-conjugated goat anti-mouse IgG
(Molecular Probes, Inc) and Alexa 488-conjugated goat
anti-rabbit IgG were used as secondary immunofluores-
cent dyes. DAPI was used to visualize DNA. Stained cells
were analyzed with a Leica TCS SP2 Confocal Spectral
Microscope using a 63X/NA 1.4 oil immersion objective
lens.
Flow cytometry
Cells were collected and fixed with 70% ethanol for 30
minutes at 0°C. Cells were stained with DNA-staining
solution (25 μg/ml propidium iodide, 100 μg/ml RNase
A, and 0.5% Nonidet P-40 in PBS) at room temperature
for 30 min. DNA content was analyzed from 10,000 cells
collected with a BD Biosciences flow cytometer in con-
junction with the CellQuest software. The distribution of
cell populations in the cell cycle stage was gated with Cel-
lQuest analysis program (M1, subG1; M2, G1; M3, S; and
M4, G2/M). The cell cycle phase distribution (in total for
100%) in each sample after CellQuest program analysis is
shown. The percentage of the cell cycle phase shown in
table is also presented with bar charts (by Microsoft
Excel).
RNA extraction and Real-time PCR
The level of gene expression was determined by real-time
PCR. Briefly, total RNA was extracted from cells using Blue
extract reagent (LTK, Inc., Taiwan) following the proce-
dures recommended by the manufacturer. Samples of 5
μg of total RNA were reverse transcribed using M-MLV
reverse transcriptase (Promega) and an oligo dT primer.






All reactions were carried out using a 7300 Real-Time PCR
System (Applied Biosystems) and ABsolute™ QPCR SYBR®
Green Mix (ABgene, Epsom, England). The amplification
was carried out as follow: initial enzyme activation at
94°C for 15 min, then 40 cycles of 94°C for 15 s and
60°C for 1 min. A total of 50 ng of each diluted reverse
transcription product was used for real-time PCR in a final
volume of 25 μl containing 160 nM of each specific
primer and 1× ABsolute™ QPCR SYBR® Green Mix
(ABgene). The relative level of Cyclin A2 gene expression
was calculated according to the comparative Ct method
using the 2-ΔΔCTCT formula, using the expression of Actin as
an endogenous control.
Authors' contributions
CWC performed most experiments and participated in the
writing of the manuscript. HYC and TCH contributed to
pull-down experiments with in vitro translated proteins.
YSL performed quantitative ChIP experiments with ectop-
ically expressed plasmids. KHH and CJC contributed to
the cloning of recombinant plasmids. SCL generated
20A1 and S473 antibodies. SCL supervised and conducted
the study and wrote the manuscript. All authors read and
approved the final manuscript draft.
Acknowledgements
We thank Drs Pierre Chambon (Institute of Genetics and Cellular and 
Molecular Biology, Strasbourg, France) for HP1 plasmids and C. K. Chou 
(Department of Life Science, Chang Gung University, Taiwan) for HA-Page 14 of 16
(page number not for citation purposes)
BMC Molecular Biology 2008, 9:61 http://www.biomedcentral.com/1471-2199/9/61PKCδ. This research was supported by a frontier science research grant 
from National Science Council of Taiwan (NSC96-2321-B002-008) and 
fund from the Institute of Biological Chemistry, Academia Sinica, Taiwan.
References
1. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Los-
son R, Chambon P: A possible involvement of TIF1 alpha and
TIF1 beta in the epigenetic control of transcription by
nuclear receptors.  EMBO J 1996, 15:6701-6715.
2. Eissenberg JC, Elgin SC: The HP1 protein family: getting a grip
on chromatin.  Curr Opin Genet Dev 2000, 10:204-210.
3. Wang G, Ma A, Chow CM, Horsley D, Brown NR, Cowell IG, Singh
PB: Conservation of heterochromatin protein 1 function.  Mol
Cell Biol 2000, 20:6970-6983.
4. Grigoryev SA, Nikitina T, Pehrson JR, Singh PB, Woodcock CL:
Dynamic relocation of epigenetic chromatin markers
reveals an active role of constitutive heterochromatin in the
transition from proliferation to quiescence.  J Cell Sci 2004,
117:6153-6162.
5. Bártová E, Pacherník J, Kozubík A, Kozubek S: Differentiation-spe-
cific association of HP1alpha and HP1beta with chromocen-
tres is correlated with clustering ofTIF1beta at c these sites.
Histochem Cell Biol 2007, 127:375-388.
6. Brasher SV, Smith BO, Fogh RH, Nietlispach D, Thiru A, Nielsen PR,
Broadhurst RW, Ball LJ, Murzina NV, Laue ED: The structure of
mouse HP1 suggests a unique mode of single peptide recog-
nition by the shadow chromo domain dimer.  EMBO J 2000,
19:1587-1597.
7. Eissenberg JC: Decisive factors: a transcription activator can
overcome heterochromatin silencing.  Bioessays 2001,
23:767-771.
8. Nielsen AL, Sanchez C, Ichinose H, Cerviño M, Lerouge T, Chambon
P, Losson R: Selective interaction between the chromatin-
remodeling factor BRG1 and the heterochromatin-associ-
ated protein HP1alpha.  EMBO J 2002, 21:5797-5806.
9. Thiru A, Nietlispach D, Mott HR, Okuwaki M, Lyon D, Nielsen PR,
Hirshberg M, Verreault A, Murzina NV, Laue ED: Structural basis
of HP1/PXVXL motif peptide interactions and HP1 localisa-
tion to heterochromatin.  EMBO J 2004, 23:489-499.
10. Vassallo MF, Tanese N: Isoform-specific interaction of HP1 with
human TAFII130.  Proc Natl Acad Sci USA 2002, 99:5919-5924.
11. Nielsen AL, Ortiz JA, You J, Oulad-Abdelghani M, Khechumian R,
Gansmuller A, Chambon P, Losson R: Interaction with members
of the heterochromatin protein 1 (HP1) family and histone
deacetylation are differentially involved in transcriptional
silencing by members of the TIF1 family.  EMBO J 1999,
18:6385-6395.
12. Cammas F, Oulad-Abdelghani M, Vonesch JL, Huss-Garcia Y, Cham-
bon P, Losson R: Cell differentiation induces TIF1beta associa-
tion with centromeric heterochromatin via an HP1
interaction.  J Cell Sci 2002, 115:3439-3448.
13. Ryan RF, Schultz DC, Ayyanathan K, Singh PB, Friedman JR, Freder-
icks WJ, Rauscher FJ 3rd: KAP1 corepressor protein interacts
and colocalizes with heterochromatic and euchromatic HP1
proteins: a potential role for Krüppel-associated box-zinc fin-
ger proteins in heterochromatin-mediated gene silencing.
Mol Cell Biol 1999, 19:4366-4378.
14. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd:
SETDB1: a novel KAP1-associated histone H3, lysine 9-spe-
cific methyltransferase that contributes to HP1-mediated
silencing of euchromatic genes by KRAB zinc-finger pro-
teins.  Genes Dev 2002, 16:919-932.
15. Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ 3rd,
Chen J: MDM2 interaction with nuclear corepressor KAP1
contributes to p53 inactivation.  EMBO J 2005, 24:3279-3290.
16. Wang C, Rauscher FJ 3rd, Cress WD, Chen J: Regulation of E2F1
function by the nuclear corepressor KAP1.  J Biol Chem 2007,
282:29902-29909.
17. Wolf D, Goff SP: TRIM28 mediates primer binding site-tar-
geted silencing of murine leukemia virus in embryonic cells.
Cell 2007, 131:46-57.
18. Li H, Rauch T, Chen ZX, Szabó PE, Riggs AD, Pfeifer GP: The his-
tone methyltransferase SETDB1 and the DNA methyltrans-
ferase DNMT3A interact directly and localize to promoters
silenced in cancer cells.  J Biol Chem 2006, 281:19489-19500.
19. Sripathy SP, Stevens J, Schultz DC: The KAP1 corepressor func-
tions to coordinate the assembly of de novo HP1-demar-
cated microenvironments of heterochromatin required for
KRAB zinc finger protein-mediated transcriptional repres-
sion.  Mol Cell Biol 2006, 26:8623-8638.
20. White DE, Negorev D, Peng H, Ivanov AV, Maul GG, Rauscher FJ 3rd:
KAP1, a novel substrate for PIKK family members, colocal-
izes with numerous damage response factors at DNA
lesions.  Cancer Res 2006, 66:11594-11599.
21. Cammas F, Mark M, Dollé P, Dierich A, Chambon P, Losson R: Mice
lacking the transcriptional corepressor TIF1beta are defec-
tive in early postimplantation development.  Development
2000, 127:2955-2963.
22. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin
SH: A protein interaction network for pluripotency of embry-
onic stem cells.  Nature 2006, 444:364-368.
23. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn
MA, Cantley LC, Gygi SP: Large-scale characterization of HeLa
cell nuclear phosphoproteins.  Proc Natl Acad Sci USA 2004,
101:12130-12135.
24. Shu H, Chen S, Bi Q, Mumby M, Brekken DL: Identification of
phosphoproteins and their phosphorylation sites in the
WEHI-231 B lymphoma cell line.  Mol Cell Proteomics 2004,
3:279-286.
25. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S,
Watson RJ, te Riele H, Dynlacht BD: E2F mediates cell cycle-
dependent transcriptional repression in vivo by recruitment
of an HDAC1/mSin3B corepressor complex.  Genes Dev 2002,
16:933-947.
26. Vigo E, Müller H, Prosperini E, Hateboer G, Cartwright P, Moroni
MC, Helin K: CDC25A phosphatase is a target of E2F and is
required for efficient E2F-induced S phase.  Mol Cell Biol 1999,
19:6379-6395.
27. Henglein B, Chenivesse X, Wang J, Eick D, Bréchot C: Structure
and cell cycle-regulated transcription of the human cyclin A
gene.  Proc Natl Acad Sci USA 1994, 91:5490-5494.
28. Aleem E, Kiyokawa H, Kaldis P: Cdc2-cyclin E complexes regu-
late the G1/S phase transition.  Nat Cell Biol 2005, 7:831-836.
29. Kenrick M, Hancock S, Stubbs S, Thomas N, GE Healthcare, The May-
nard Centre, Cardiff, UK: siRNA screening of the cell cycle with






30. Belhacène N, Maulon L, Guérin S, Ricci JE, Mari B, Colin Y, Cartron
JP, Auberger P: Differential expression of the Kell blood group
and CD10 antigens: two related membrane metallopepti-
dases during differentiation of K562 cells by phorbol ester
and hemin.  FASEB J 1998, 12:531-539.
31. Rosson D, O'Brien TG: Constitutive c-myb expression in K562
cells inhibits induced erythroid differentiation but not tetra-
decanoyl phorbol acetate-induced megakaryocytic differen-
tiatio.  Mol Cell Biol 1995, 15:772-779.
32. Urrutia R: KRAB-containing zinc-finger repressor proteins.
Genome Biol 2003, 4:231.
33. Cammas F, Janoshazi A, Lerouge T, Losson R: Dynamic and selec-
tive interactions of the transcriptional corepressor TIF1
beta with the heterochromatin protein HP1 isotypes during
cell differentiation.  Differentiation 2007, 75:627-637.
34. Hsu SI, Yang CM, Sim KG, Hentschel DM, O'Leary E, Bonventre JV:
TRIP-Br: a novel family of PHD zinc finger- and bromodo-
main-interacting proteins that regulate the transcriptional
activity of E2F-1/DP-1.  EMBO J 2001, 20:2273-2285.
35. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, Ann DK: Role for
KAP1 serine 824 phosphorylation and sumoylation/des-
umoylation switch in regulating KAP1-mediated transcrip-
tional repression.  J Biol Chem 2007, 282:36177-36189.
36. Jain N, Zhang T, Kee WH, Li W, Cao X: Protein kinase C delta
associates with and phosphorylates Stat3 in an interleukin-6-
dependent manner.  J Biol Chem 1999, 274:24392-24400.
37. Novotny-Diermayr V, Zhang T, Gu L, Cao X: Protein kinase C
delta associates with the interleukin-6 receptor subunit glyc-
oprotein (gp) 130 via Stat3 and enhances Stat3-gp130 inter-
action.  J Biol Chem 2002, 277:49134-49142.Page 15 of 16
(page number not for citation purposes)
BMC Molecular Biology 2008, 9:61 http://www.biomedcentral.com/1471-2199/9/61Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
38. Shen S, Alt A, Wertheimer E, Gartsbein M, Kuroki T, Ohba M,
Braiman L, Sampson SR, Tennenbaum T: PKCdelta activation: a
divergence point in the signaling of insulin and IGF-1-induced
proliferation of skin keratinocytes.  Diabetes 2001, 50:255-264.
39. Brand C, Cipok M, Attali V, Bak A, Sampson SR: Protein kinase Cδ
participates in insulin-induced activation of PKB via PDK1.
Biochem Biophys Res Commun 2006, 349:954-962.
40. Gartsbein M, Alt A, Hashimoto K, Nakajima K, Kuroki T, Tennen-
baum T: The role of protein kinase C delta activation and
STAT3 Ser727 phosphorylation in insulin-induced keratino-
cyte proliferation.  J Cell Sci 2006, 119:470-481.
41. Kajimoto T, Ohmori S, Shirai Y, Sakai N, Saito N: Subtype-specific
translocation of the delta subtype of protein kinase C and its
activation by tyrosine phosphorylation induced by ceramide
in HeLa cells.  Mol Cell Biol 2001, 21:1769-1783.
42. Cammas F, Herzog M, Lerouge T, Chambon P, Losson R: Associa-
tion of the transcriptional corepressor TIF1beta with hete-
rochromatin protein 1 (HP1): an essential role for
progression through differentiation.  Genes Dev 2004,
18:2147-2160.
43. Chang CJ, Chen YL, Lee SC: Coactivator TIF1beta interacts
with transcription factor C/EBPbeta and glucocorticoid
receptor to induce alpha1-acid glycoprotein gene expres-
sion.  Mol Cell Biol 1998, 18:5880-5887.
44. Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BW: Progesterone and
glucocorticoid receptors recruit distinct coactivator com-
plexes and promote distinct patterns of local chromatin
modification.  Mol Cell Biol 2003, 23:3763-3773.Page 16 of 16
(page number not for citation purposes)
